← 產業報告目錄

Single Cell Sequencing Market by Product (Reagents & Kits, Platforms, Software), Workflow (Presequencing), Service (Sample Preparation, Bioinformatics), Sequencing (scRNA, scDNA), Application (Research, Diagnostic), End User - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2025-08-25頁數 622報告編號 BT9503

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The single-cell sequencing market is expected to reach USD 3.46 billion in 2030 from USD 1.95 billion in 2025, at a CAGR of 12.2% during the forecast period. The growth of this market can be attributed to ongoing technological advancements in single-cell sequencing technologies, which are becoming more accurate, scalable, and efficient. For instance, in July 2025, researchers from the Huazhong University of Science and Technology developed the Toti-N-Seq platform to overcome challenges in sample multiplexing and rare cell detection by using a special glycan-binding protein to label all types of cells and nuclei. At the same time, well-established systems like 10x Genomics’ Chromium remain essential for extensive studies due to their reliability, high throughput, and broad adoption. “By type, the sequencing instruments segment is expected to register the highest growth rate during the forecast period.” By type, the single-cell sequencing products market is segmented into consumables, instruments, and software. The instruments segment is further segmented into pre-sequencing and sequencing instruments. The sequencing instruments segment registered the highest CAGR during the forecast period. This growth is primarily driven by the emergence of new sequencing technology providers, such as Pacific Biosciences (PacBio), Oxford Nanopore Technologies, Element Biosciences, and Ultima Genomics, that have introduced platforms compatible with various single-cell sequencing workflows. Additionally, sequencing instruments remain the core technological driver of single-cell sequencing, performing the essential function of decoding nucleic acids at single-cell resolution. As applications of single-cell sequencing expand into areas like oncology, immunology, neuroscience, and microbiome studies, there is a corresponding rise in demand for sequencing instruments capable of handling increasingly complex, large-scale datasets. “By service type, the sequencing services segment accounted for the largest share of the market in 2024.” Based on service type, the single-cell sequencing market is pre-sequencing services, sequencing services, and data analysis & bioinformatic services. In 2024, the sequencing services segment held the largest share of the single-cell sequencing market by service type. The large share of this service segment can be attributed to the high cost and operational complexity of sequencing instruments. The growing demand for clinical-grade sequencing, higher throughput, and standardized data output has also driven the expansion of professional sequencing services, reinforcing their leading position in the market. Moreover, with the rising adoption of single-cell technologies in translational research and clinical studies, sequencing services offer a scalable and compliant solution for handling large sample volumes. “The Asia Pacific region is expected to grow at the highest CAGR in the single-cell sequencing market during the forecast period.” The market is segmented by region into North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. The Asia Pacific region is projected to register the highest CAGR in the single-cell sequencing market during the forecast period. The key factors driving the market growth include expanding biomedical research infrastructure, rising government funding, and increasing adoption of single-cell technologies in clinical and academic settings. Countries like China, Japan, and South Korea actively invest in genomics through national initiatives and grants. At the same time, companies such as Singleron Biotechnologies and Macrogen make the technology more accessible across research and diagnostic markets. The region’s large and genetically diverse populations offer vast opportunities for disease-specific single-cell studies, particularly in oncology and infectious diseases. Additionally, lower operational costs and growing outsourcing of sequencing services to Asia-based CROs further accelerate regional growth, making the Asia Pacific a key engine of expansion for the global single-cell sequencing market. The primary interviews conducted for this report can be categorized as follows: • By Company Type: Tier 1- 44%, Tier 2- 32%, and Tier 3- 24% • By Designation: (Managers)- 45%, (CXOs, Directors)- 30%, and (Executives)- 25% • By Region: North America- 40%, Europe- 25%, Asia Pacific- 20%, and the Rest of the World- 15% 10x Genomics (US), Illumina Inc. (US), BD (US), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), QIAGEN (Netherlands), Bio-Techne (US), and PacBio (US) are some of the key players in the single-cell sequencing market. The study includes an in-depth competitive analysis of these key players in the single-cell sequencing market, with their company profiles, recent developments, and key market strategies. Research Coverage: This research report categorizes the single cell sequencing market by offering (products, services), by product type (consumables [pre-sequencing, sequencing], instruments [pre-sequencing instruments {microfluidics, PCR, LCM, FACs, others}, sequencing platforms], software), by product workflow (pre-sequencing, sequencing, software), by product end user (hospitals & diagnostic laboratories, academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations), by service type (pre-sequencing services [sample preparation, library preparation], sequencing services, bioinformatics services), by service end users (hospitals & diagnostic laboratories, academic & research institutes, pharmaceutical & biotechnology companies), by sequencing type (single cell transciptome sequencing, single cell genome sequencing, single cell ATAC sequencing, others), by application (research application [basic & translation research {cancer research, stem cell & developmental biology, neurology & brain research, microbiology & infectious disease, organ development & regenerative medicine}, drug discovery & development], diagnostic & clinical application), by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The report provides in-depth information on significant factors influencing the growth of the single-cell sequencing market, including drivers, trends, challenges, and opportunities. A thorough analysis of major industry players has been undertaken to provide insights into their business profiles, products/services, key strategies, collaborations, partnerships, and agreements. Additionally, the report encompasses recent developments such as new product launches and acquisitions within the single-cell sequencing market. Key Benefits of Buying the Report: The report will help market leaders/new entrants by providing the closest approximations of the revenue numbers for the overall single-cell sequencing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges. The report provides insights into the following pointers: • Analysis of key drivers (Advancements in Single-Cell sequencing technologies, Growing Demand for Personalized Medicine and Biomarker Discovery, Integration of AI and ML in data analysis, Advantages over bulk sequencing), restraints (High cost of single cell sequencing and analysis products), opportunities (Development of Sequencing by Expansion (SBX) technology, Growing clinical applications), and challenges (Data Complexities and Analysis Bottleneck) influencing the growth of the market. • Product Development/Innovation: Detailed insights on newly launched products/services of the single-cell sequencing market • Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions. • Market Diversification: Exhaustive information about new products/services, untapped geographies, recent developments, and investments in the single-cell sequencing market • Competitive Assessment: In-depth assessment of market share, growth strategies and service offerings of leading players like 10x Genomics (US), Illumina Inc. (US), BD (US), Danaher (US), Thermo Fisher Scientific Inc. (US), Qiagen (Netherlands), and Pacbio (US) among others, in the single-cell sequencing market.
目錄 Table of Contents
1 INTRODUCTION 52 1.1 STUDY OBJECTIVES 52 1.2 MARKET DEFINITION 52 1.3 MARKET SCOPE 52 1.3.1 MARKETS & REGIONS COVERED 53 1.3.2 INCLUSIONS & EXCLUSIONS 54 1.3.3 YEARS CONSIDERED 56 1.3.4 CURRENCY CONSIDERED 56 1.4 MARKET STAKEHOLDERS 56 2 RESEARCH METHODOLOGY 57 2.1 RESEARCH DATA 57 2.1.1 SECONDARY DATA 58 2.1.2 PRIMARY DATA 59 2.2 MARKET ESTIMATION METHODOLOGY 60 2.2.1 MARKET SIZE ESTIMATION 60 2.2.2 SEGMENTAL MARKET ASSESSMENT 63 2.3 MARKET GROWTH RATE PROJECTIONS 65 2.4 DATA TRIANGULATION 68 2.5 RESEARCH ASSUMPTIONS 69 2.6 RESEARCH LIMITATIONS 70 2.7 RISK ASSESSMENT 71 3 EXECUTIVE SUMMARY 72 3.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 72 3.2 STRATEGIC IMPERATIVES FOR STAKEHOLDERS 79 3.3 DISRUPTIVE TRENDS SHAPING MARKET 80 4 PREMIUM INSIGHTS 81 4.1 SINGLE-CELL SEQUENCING MARKET SNAPSHOT 81 4.2 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING & COUNTRY (2024) 82 4.3 SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE (2024) 82 4.4 SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER (2024) 83 4.5 SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER (2024) 83 4.6 SINGLE-CELL SEQUENCING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 84   5 MARKET OVERVIEW 85 5.1 INTRODUCTION 85 5.2 MARKET DYNAMICS 85 5.2.1 DRIVERS 86 5.2.1.1 Advancements in single-cell sequencing technologies 86 5.2.1.2 Growing focus on precision medicine and biomarker discovery 87 5.2.1.3 Integration of AI & ML in data analysis 88 5.2.1.4 Advantages over conventional bulk sequencing 88 5.2.2 RESTRAINTS 89 5.2.2.1 High cost of single-cell sequencing products & services 89 5.2.3 OPPORTUNITIES 89 5.2.3.1 Emergence of SBX technology 89 5.2.3.2 Integration of multi-omics technologies 90 5.2.3.3 Growth potential of emerging economies 91 5.2.4 CHALLENGES 92 5.2.4.1 Complexities associated with high-dimensional single-cell data 92 5.2.4.2 Biological variability and cell heterogeneity 92 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 92 5.4 VALUE CHAIN ANALYSIS 94 5.5 ECOSYSTEM ANALYSIS 96 5.5.1 EMERGING BUSINESS MODELS AND ECOSYSTEM SHIFT IN SINGLE-CELL SEQUENCING MARKET 98 5.6 TECHNOLOGY ANALYSIS 99 5.6.1 KEY TECHNOLOGIES 99 5.6.1.1 Microfluidics partitioning 99 5.6.1.2 NGS 99 5.6.1.3 PCR 99 5.6.1.4 Flow cytometry 100 5.6.2 COMPLEMENTARY TECHNOLOGIES 100 5.6.2.1 Magnetic-activated Cell Sorting (MACS) 100 5.6.2.2 Tissue dissociation systems 100 5.6.2.3 Combinatorial indexing 100 5.6.3 ADJACENT TECHNOLOGIES 101 5.6.3.1 Bulk RNA-seq 101 5.6.3.2 In situ hybridization (ISH) 101 5.7 PATENT ANALYSIS 101 5.7.1 PATENT METHODOLOGY 101 5.7.2 PATENTS APPLIED & GRANTED, 2014–2024 102 5.8 TRADE ANALYSIS 104 5.8.1 IMPORT DATA (HS CODE 9027) 104 5.8.2 EXPORT DATA (HS CODE 9027) 106   5.9 PORTER’S FIVE FORCES ANALYSIS 107 5.9.1 THREAT OF NEW ENTRANTS 109 5.9.2 THREAT OF SUBSTITUTES 109 5.9.3 BARGAINING POWER OF SUPPLIERS 109 5.9.4 BARGAINING POWER OF BUYERS 109 5.9.5 INTENSITY OF COMPETITIVE RIVALRY 110 5.10 TARIFF & REGULATORY LANDSCAPE 110 5.10.1 TARIFF DATA (HS CODE 9027) 110 5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111 5.10.3 REGULATORY FRAMEWORK 114 5.11 PRICING ANALYSIS 117 5.11.1 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2022 —2024 117 5.11.2 AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2024 119 5.12 KEY CONFERENCES & EVENTS, 2025–2026 120 5.13 KEY STAKEHOLDERS & BUYING CRITERIA 121 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 121 5.13.2 ROLE OF STAKEHOLDERS IN BUYING PROCESS 122 5.13.3 BUYING CRITERIA 123 5.14 CUSTOMER LANDSCAPE 124 5.14.1 STRATEGIC ANALYSIS OF GROWTH OPPORTUNITIES 124 5.14.2 UNMET NEEDS & WHITE SPACES 126 5.15 INVESTMENT & FUNDING ACTIVITIES 126 5.16 IMPACT OF AI/GENERATIVE AI ON SINGLE-CELL SEQUENCING MARKET 127 5.16.1 AI-USE CASES 128 5.16.2 KEY COMPANIES IMPLEMENTING AI 129 5.16.3 FUTURE OF AI IN SINGLE-CELL SEQUENCING 129 5.17 TRUMP TARIFF IMPACT ON SINGLE-CELL SEQUENCING MARKET 130 5.17.1 INTRODUCTION 130 5.17.2 KEY TARIFF RATES 130 5.17.3 PRICE IMPACT ANALYSIS 131 5.17.4 KEY IMPACT ON VARIOUS REGIONS 132 5.17.4.1 US 132 5.17.4.2 Europe 132 5.17.4.3 Asia Pacific 133 5.17.4.4 Rest of the World 133 5.17.5 END-USE INDUSTRY IMPACT 133 5.17.5.1 Pharmaceutical & biotech companies 133 5.17.5.2 CROs 134 5.17.5.3 Academic & research institutes 134 5.17.5.4 Hospitals & clinical laboratories 134 6 SINGLE-CELL SEQUENCING MARKET, BY OFFERING 135 6.1 INTRODUCTION 136 6.2 PRODUCTS 136 6.2.1 RECURRING DEMAND FOR CONSUMABLES TO DRIVE MARKET 136 6.3 SERVICES 140 6.3.1 HIGH RELIANCE ON SERVICE PROVIDERS FOR SEQUENCING ACTIVITIES TO PROPEL MARKET 140 7 SINGLE-CELL SEQUENCING PRODUCT MARKET, BY TYPE 144 7.1 INTRODUCTION 145 7.2 CONSUMABLES 145 7.2.1 PRE-SEQUENCING REAGENTS & KITS 146 7.2.1.1 Ongoing product launches & upgrades to fuel uptake 146 7.2.2 SEQUENCING REAGENTS & KITS 150 7.2.2.1 Ability to provide high-throughput and high-fidelity nucleotide reading to boost demand 150 7.3 INSTRUMENTS 153 7.3.1 PRE-SEQUENCING INSTRUMENTS 154 7.3.1.1 Microfluidic instruments 158 7.3.1.1.1 Increasing demand for reproducible & low-input single-cell workflows to fuel uptake 158 7.3.1.2 Cell sorters 161 7.3.1.2.1 Provision of high-precision isolation of viable cells to boost demand 161 7.3.1.3 PCR instruments 164 7.3.1.3.1 High sensitivity & reproducibility features to fuel uptake 164 7.3.1.4 LCM instruments 167 7.3.1.4.1 Increasing use across applications requiring spatial resolution to support demand 167 7.3.1.5 Other pre-sequencing instruments 170 7.3.2 SEQUENCING PLATFORMS 173 7.3.2.1 Rising adoption across research applications to drive market 173 7.4 SOFTWARE 177 7.4.1 SOFTWARE TOOLS 180 7.4.1.1 Rising demand for accurate & scalable processing of sequencing data to support market growth 180 7.4.2 DATA STORAGE & MANAGEMENT SOFTWARE 183 7.4.2.1 Secure handling, archival, and retrieval of large volumes of data to support market growth 183   8 SINGLE-CELL SEQUENCING PRODUCT MARKET, BY WORKFLOW 187 8.1 INTRODUCTION 188 8.2 PRE-SEQUENCING WORKFLOW 188 8.2.1 ABILITY TO ENABLE HIGH-THROUGHPUT WORKFLOW IN CLINICAL & RESEARCH SETTINGS TO DRIVE MARKET 188 8.3 SEQUENCING WORKFLOW 192 8.3.1 DEMAND FOR MULTI-OMIC SEQUENCING PLATFORMS IN TRANSLATIONAL RESEARCH & ONCOLOGY TO PROPEL MARKET 192 8.4 DATA ANALYSIS & INTERPRETATION WORKFLOW 195 8.4.1 COMPLEXITY OF SINGLE-CELL DATASETS TO FUEL MARKET 195 9 SINGLE-CELL SEQUENCING PRODUCT MARKET, BY END USER 199 9.1 INTRODUCTION 200 9.2 ACADEMIC & RESEARCH INSTITUTES 200 9.2.1 RISING FOCUS ON LIFE SCIENCES RESEARCH SUPPORTED BY FAVORABLE GRANTS & FUNDS TO DRIVE MARKET 200 9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 204 9.3.1 INCREASING DEMAND FOR DRUG DISCOVERY & DEVELOPMENT TO PROPEL MARKET 204 9.4 HOSPITALS & CLINICAL LABORATORIES 207 9.4.1 RISING INTEGRATION OF ADVANCED SEQUENCING TECHNOLOGIES INTO CLINICAL WORKFLOWS TO BOOST DEMAND 207 9.5 CONTRACT RESEARCH ORGANIZATIONS (CROS) 211 9.5.1 INCREASING RELIANCE ON OUTSOURCING R&D ACTIVITIES TO SUPPORT MARKET GROWTH 211 10 SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE 215 10.1 INTRODUCTION 216 10.2 PRE-SEQUENCING SERVICES 216 10.2.1 SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES 220 10.2.1.1 Rising demand for high-resolution cell profiling services to fuel market 220 10.2.2 LIBRARY PREPARATION SERVICES 224 10.2.2.1 Adoption of single-cell applications to fuel market 224 10.3 SEQUENCING SERVICES 227 10.3.1 INCREASING DEMAND FOR SCALABLE & APPLICATION-SPECIFIC SEQUENCING OUTPUTS TO DRIVE MARKET 227 10.4 DATA ANALYSIS & BIOINFORMATICS SERVICES 231 10.4.1 INCREASING FOCUS ON CREATION OF END-TO-END ANALYSIS PIPELINES TO SUPPORT MARKET GROWTH 231   11 SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER 235 11.1 INTRODUCTION 236 11.2 ACADEMIC & RESEARCH INSTITUTES 236 11.2.1 EXECUTION OF COMPLEX & LARGE-SCALE CELLULAR STUDIES TO DRIVE MARKET 236 11.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 240 11.3.1 INTEGRATION OF HIGH-THROUGHPUT SINGLE-CELL PLATFORMS IN DRUG DISCOVERY ACTIVITIES TO PROPEL MARKET 240 11.4 HOSPITALS & CLINICAL LABORATORIES 243 11.4.1 INCREASING USE ACROSS ONCOLOGY DIAGNOSTICS TO SUPPORT MARKET GROWTH 243 12 SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE 247 12.1 INTRODUCTION 248 12.2 SINGLE-CELL TRANSCRIPTOME SEQUENCING (SCRNA-SEQ) 248 12.2.1 WIDE APPLICATIONS FOR GENE EXPRESSION STUDIES TO DRIVE MARKET 248 12.3 SINGLE-CELL GENOME SEQUENCING (SCDNA-SEQ) 252 12.3.1 ANALYSIS OF GENOMIC VARIATIONS WITH COMPLEX ADVANCEMENTS TO FUEL MARKET 252 12.4 SINGLE-CELL ATAC SEQUENCING (SCATAC-SEQ) 255 12.4.1 IDENTIFICATION OF OPEN DNA REGIONS TO SUPPORT MARKET GROWTH 255 12.5 OTHER SINGLE-CELL SEQUENCING TYPES 259 13 SINGLE-CELL SEQUENCING MARKET, BY APPLICATION 263 13.1 INTRODUCTION 264 13.2 RESEARCH APPLICATIONS 264 13.2.1 BASIC & TRANSLATION RESEARCH 265 13.2.1.1 Cancer research 266 13.2.1.1.1 Growing demand for oncology therapeutics to drive market 266 13.2.1.2 Stem cell & developmental biology 270 13.2.1.2.1 Mapping stem cell heterogeneity and lineage dynamics with high precision to boost demand 270 13.2.1.3 Neurology & brain research 273 13.2.1.3.1 Growing focus on psychiatric & neurodevelopmental disorder research to fuel market 273 13.2.1.4 Microbiology & infectious diseases 277 13.2.1.4.1 Precise profiling of immune responses & pathogen behavior to boost demand 277 13.2.1.5 Organ development & regenerative medicine 280 13.2.1.5.1 Growing focus on precision medicine to fuel uptake 280 13.2.2 DRUG DISCOVERY & DEVELOPMENT 283 13.2.2.1 Improved target validation and patient stratification using single-cell data to drive market 283   13.3 DIAGNOSTIC & CLINICAL APPLICATIONS 287 13.3.1 RISING UPTAKE IN MOLECULAR DIAGNOSTICS & PERSONALIZED MEDICINE TO SUPPORT MARKET GROWTH 287 14 SINGLE-CELL SEQUENCING MARKET, BY REGION 291 14.1 INTRODUCTION 292 14.2 NORTH AMERICA 292 14.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 293 14.2.2 US 301 14.2.2.1 Increasing R&D investments & funding to drive market 301 14.2.3 CANADA 308 14.2.3.1 High prevalence of hemophilia to propel market 308 14.3 EUROPE 315 14.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 315 14.3.2 GERMANY 324 14.3.2.1 Increasing awareness of advanced cell therapies to drive market 324 14.3.3 UK 330 14.3.3.1 Rising adoption of single-cell analysis products to boost demand 330 14.3.4 FRANCE 337 14.3.4.1 Favorable government funding investments for genomics to fuel market 337 14.3.5 ITALY 344 14.3.5.1 Growing focus on cell biology research to fuel uptake 344 14.3.6 SPAIN 350 14.3.6.1 Increasing number of biotechnology companies to drive market 350 14.3.7 REST OF EUROPE 357 14.4 ASIA PACIFIC 364 14.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 365 14.4.2 CHINA 373 14.4.2.1 Increasing incidence of infectious diseases to drive market 373 14.4.3 JAPAN 379 14.4.3.1 Growing demand for personalized medicine to drive market 379 14.4.4 INDIA 386 14.4.4.1 Expansion of activities in cell biology and biotech sectors to drive market 386 14.4.5 SOUTH KOREA 393 14.4.5.1 Increasing number of strategic alliances to boost market 393 14.4.6 AUSTRALIA 400 14.4.6.1 Rising establishment of life science companies to boost demand 400 14.4.7 REST OF ASIA PACIFIC 407   14.5 LATIN AMERICA 414 14.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 414 14.5.2 BRAZIL 421 14.5.2.1 Focus on advancements in manufacturing infrastructure for biopharmaceuticals to propel market 421 14.5.3 MEXICO 428 14.5.3.1 Favorable government support for advanced sequencing technologies to drive market 428 14.5.4 REST OF LATIN AMERICA 435 14.6 MIDDLE EAST 442 14.6.1 MACROECONOMIC OUTLOOK IN MIDDLE EAST 442 14.6.2 GCC COUNTRIES 450 14.6.2.1 Kingdom of Saudi Arabia (KSA) 458 14.6.2.1.1 Increasing healthcare expenditure to drive market 458 14.6.2.2 United Arab Emirates 464 14.6.2.2.1 Improvements in medical sector to fuel uptake 464 14.6.2.3 Other GCC Countries 471 14.6.3 REST OF MIDDLE EAST 478 14.7 AFRICA 485 14.7.1 RISING FOCUS ON DRUG DISCOVERY & DEVELOPMENT TO SUPPORT MARKET GROWTH 485 14.7.2 MACROECONOMIC OUTLOOK FOR AFRICA 486 15 COMPETITIVE LANDSCAPE 493 15.1 OVERVIEW 493 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2025 493 15.3 REVENUE ANALYSIS, 2022–2024 496 15.4 MARKET SHARE ANALYSIS, 2024 497 15.5 COMPANY EVALUATION MATRIX: KEY PRODUCT PROVIDERS, 2024 500 15.5.1 STARS 500 15.5.2 EMERGING LEADERS 500 15.5.3 PERVASIVE PLAYERS 500 15.5.4 PARTICIPANTS 501 15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 502 15.5.5.1 Company footprint 502 15.5.5.2 Region footprint 503 15.5.5.3 Product type footprint 504 15.5.5.4 Workflow footprint 505 15.5.5.5 Application footprint 507   15.6 COMPANY EVALUATION MATRIX: KEY SERVICE PROVIDERS, 2024 508 15.6.1 STARS 508 15.6.2 EMERGING LEADERS 508 15.6.3 PERVASIVE PLAYERS 508 15.6.4 PARTICIPANTS 508 15.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 510 15.6.5.1 Company footprint 510 15.6.5.2 Region footprint 511 15.6.5.3 Service footprint 512 15.6.5.4 Application footprint 512 15.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 513 15.7.1 PROGRESSIVE COMPANIES 513 15.7.2 RESPONSIVE COMPANIES 513 15.7.3 DYNAMIC COMPANIES 513 15.7.4 STARTING BLOCKS 513 15.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 515 15.7.5.1 Detailed list of key startups/SMEs 515 15.7.5.2 Competitive benchmarking of key startups/SMEs 517 15.8 COMPANY VALUATION & FINANCIAL METRICS 518 15.8.1 FINANCIAL METRICS 518 15.8.2 COMPANY VALUATION 518 15.9 BRAND/PRODUCT COMPARISON 519 15.9.1 BRAND/PRODUCT COMPARATIVE ANALYSIS 519 15.10 COMPETITIVE SCENARIO 520 15.10.1 PRODUCT & SERVICE LAUNCHES 520 15.10.2 DEALS 522 16 COMPANY PROFILES 524 16.1 INTRODUCTION 524 16.2 KEY PRODUCT PROVIDERS 524 16.2.1 BECTON, DICKINSON AND COMPANY (BD) 524 16.2.1.1 Business overview 524 16.2.1.2 Products offered 526 16.2.1.3 Recent developments 527 16.2.1.3.1 Product launches 527 16.2.1.3.2 Deals 529 16.2.1.4 MnM view 529 16.2.1.4.1 Key strengths 529 16.2.1.4.2 Strategic choices 530 16.2.1.4.3 Weaknesses & competitive threats 530   16.2.2 THERMO FISHER SCIENTIFIC INC. 531 16.2.2.1 Business overview 531 16.2.2.2 Products offered 532 16.2.2.3 Recent developments 534 16.2.2.3.1 Product launches 534 16.2.2.4 MnM view 534 16.2.2.4.1 Key strengths 534 16.2.2.4.2 Strategic choices 535 16.2.2.4.3 Weaknesses & competitive threats 535 16.2.3 DANAHER CORPORATION 536 16.2.3.1 Business overview 536 16.2.3.2 Products offered 537 16.2.3.3 Recent developments 539 16.2.3.3.1 Product launches 539 16.2.3.3.2 Deals 540 16.2.3.4 MnM view 540 16.2.3.4.1 Key strengths 540 16.2.3.4.2 Strategic choices 540 16.2.3.4.3 Weaknesses & competitive threats 540 16.2.4 10X GENOMICS 541 16.2.4.1 Business overview 541 16.2.4.2 Products offered 542 16.2.4.3 Recent developments 544 16.2.4.3.1 Product launches 544 16.2.4.3.2 Deals 545 16.2.4.4 MnM view 546 16.2.4.4.1 Key strengths 546 16.2.4.4.2 Strategic choices 547 16.2.4.4.3 Weaknesses & competitive threats 547 16.2.5 ILLUMINA, INC. 548 16.2.5.1 Business overview 548 16.2.5.2 Products offered 549 16.2.5.3 Recent developments 551 16.2.5.3.1 Product launches 551 16.2.5.3.2 Deals 552 16.2.5.4 MnM view 552 16.2.5.4.1 Key strengths 552 16.2.5.4.2 Strategic choices 553 16.2.5.4.3 Weaknesses & competitive threats 553   16.2.6 MERCK KGAA 554 16.2.6.1 Business overview 554 16.2.6.2 Products offered 556 16.2.7 QIAGEN N.V. 558 16.2.7.1 Business overview 558 16.2.7.2 Products offered 560 16.2.8 BIO-RAD LABORATORIES, INC. 561 16.2.8.1 Business overview 561 16.2.8.2 Products offered 562 16.2.8.3 Recent developments 564 16.2.8.3.1 Product launches 564 16.2.9 TECAN TRADING AG 565 16.2.9.1 Business overview 565 16.2.9.2 Products offered 566 16.2.9.3 Recent developments 567 16.2.9.3.1 Product launches 567 16.2.9.3.2 Deals 568 16.2.10 CYTEK BIOSCIENCES 569 16.2.10.1 Business overview 569 16.2.10.2 Products offered 570 16.2.10.3 Recent developments 570 16.2.10.3.1 Product launches 570 16.2.10.3.2 Deals 570 16.2.10.3.3 Expansions 571 16.2.11 TAKARA BIO INC. 572 16.2.11.1 Business overview 572 16.2.11.2 Products offered 573 16.2.11.3 Recent developments 575 16.2.11.3.1 Product launches 575 16.2.11.3.2 Deals 575 16.2.12 BIO-TECHNE 576 16.2.12.1 Business overview 576 16.2.12.2 Products offered 577 16.2.12.3 Recent developments 578 16.2.12.3.1 Deals 578 16.2.13 PACBIO 579 16.2.13.1 Business overview 579 16.2.13.2 Products offered 580 16.2.13.3 Recent developments 581 16.2.13.3.1 Product launches 581   16.3 KEY SERVICE PROVIDERS 582 16.3.1 AZENTA US INC. 582 16.3.1.1 Business overview 582 16.3.1.2 Services offered 583 16.3.2 NOVOGENE CO., LTD. 585 16.3.2.1 Business overview 585 16.3.2.2 Services Offered 585 16.3.2.3 Recent developments 586 16.3.2.3.1 Service launches 586 16.3.2.3.2 Expansions 586 16.3.3 IQVIA INC. 588 16.3.3.1 Business overview 588 16.3.3.2 Services offered 589 16.3.4 ALMAC GROUP 590 16.3.4.1 Business overview 590 16.3.4.2 Services offered 590 16.3.5 CEGAT GMBH 591 16.3.5.1 Business overview 591 16.3.5.2 Services offered 591 16.3.6 ACTIVE MOTIF 592 16.3.6.1 Business overview 592 16.3.6.2 Services offered 592 16.4 OTHER PRODUCT PROVIDERS 593 16.4.1 SINGLERON BIOTECHNOLOGIES 593 16.4.2 CELL MICROSYSTEMS 594 16.4.3 NANOCELLECT BIOMEDICAL 595 16.4.4 OXFORD NANOPORE TECHNOLOGIES PLC. 596 16.4.5 REVVITY 597 16.4.6 PARSE BIOSCIENCES 598 16.4.7 ULTIMA GENOMICS 599 16.4.8 MISSION BIO 600 16.5 OTHER SERVICE PROVIDERS 601 16.5.1 SINGLE CELL DISCOVERIES BV 601 16.5.2 ADMERA HEALTH 602 16.5.3 BGI 603 16.5.4 SIGNIOSBIO 604 16.5.5 MACROGEN CO., LTD. 605 16.5.6 LEXOGEN GMBH 606 16.5.7 DISCOVERY LIFE SCIENCES 607 16.5.8 CELLCARTA 608 16.5.9 SINGULOMICS CORPORATION 609 16.5.10 SEQMATIC LLC. 610 17 APPENDIX 611 17.1 DISCUSSION GUIDE 611 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 617 17.3 CUSTOMIZATION OPTIONS 619 17.4 RELATED REPORTS 620 17.5 AUTHOR DETAILS 621
圖表清單 List of Tables & Figures
TABLE 1 SINGLE-CELL SEQUENCING MARKET: INCLUSIONS & EXCLUSIONS 54 TABLE 2 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 68 TABLE 3 SINGLE-CELL SEQUENCING MARKET: RISK ASSESSMENT ANALYSIS 71 TABLE 4 SINGLE-CELL SEQUENCING MARKET: IMPACT ANALYSIS 86 TABLE 5 SINGLE-CELL SEQUENCING MARKET: RAW MATERIAL VENDORS 97 TABLE 6 SINGLE-CELL SEQUENCING MARKET: EMERGING BUSINESS MODELS & STRATEGIC ADVANTAGE 98 TABLE 7 PATENTS APPLIED & GRANTED, 2014–2024 102 TABLE 8 INNOVATIONS & PATENT REGISTRATIONS, 2024 103 TABLE 9 IMPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (USD THOUSANDS) 104 TABLE 10 IMPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (TONS) 105 TABLE 11 EXPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (USD THOUSANDS) 106 TABLE 12 EXPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (TONS) 107 TABLE 13 SINGLE-CELL SEQUENCING MARKET: PORTER’S FIVE FORCES ANALYSIS 108 TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111 TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111 TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 112 TABLE 17 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 113 TABLE 18 SINGLE-CELL SEQUENCING MARKET: REGULATORY GUIDELINES 114 TABLE 19 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2022–2024 117 TABLE 20 AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2024 119 TABLE 21 SINGLE-CELL SEQUENCING MARKET: KEY CONFERENCES & EVENTS, 2025–2026 120 TABLE 22 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR SINGLE-CELL SEQUENCING PRODUCTS 122 TABLE 23 BUYING CRITERIA FOR SINGLE-CELL SEQUENCING PRODUCTS, BY END USER 123 TABLE 24 SINGLE-CELL SEQUENCING MARKET: STRATEGIC ANALYSIS OF GROWTH OPPORTUNITIES 124 TABLE 25 KEY COMPANIES IMPLEMENTING AI IN SINGLE-CELL SEQUENCING MARKET 129 TABLE 26 KEY PRODUCT-RELATED TARIFF: MISCELLANEOUS CHEMICAL PRODUCTS, ELECTRICAL MACHINERY & EQUIPMENT, AND PARTS THEREOF. 131 TABLE 27 SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 136 TABLE 28 SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 137 TABLE 29 NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 30 EUROPE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 31 ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 32 LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 33 MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 139 TABLE 34 GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 35 SINGLE-CELL SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 140 TABLE 36 NORTH AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 37 EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 38 ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 39 LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 40 MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 142 TABLE 41 GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 42 SINGLE-CELL SEQUENCING PRODUCT MARKET, BY TYPE, 2023–2030 (USD MILLION) 145 TABLE 43 SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 146 TABLE 44 PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION) 147 TABLE 45 NORTH AMERICA: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 46 EUROPE: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 47 ASIA PACIFIC: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 48 LATIN AMERICA: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 49 MIDDLE EAST: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION) 149 TABLE 50 GCC COUNTRIES: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 51 SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION) 150 TABLE 52 NORTH AMERICA: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 151 TABLE 53 EUROPE: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 151 TABLE 54 ASIA PACIFIC: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 152 TABLE 55 LATIN AMERICA: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 152 TABLE 56 MIDDLE EAST: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION) 153 TABLE 57 GCC COUNTRIES: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 58 SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 154 TABLE 59 PRE-SEQUENCING INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 154 TABLE 60 NORTH AMERICA: PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 61 EUROPE: PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 62 ASIA PACIFIC: PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 63 LATIN AMERICA: PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 64 MIDDLE EAST: PRE-SEQUENCING INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 157 TABLE 65 GCC COUNTRIES: PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 157 TABLE 66 PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 157 TABLE 67 MICROFLUIDIC INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 158 TABLE 68 NORTH AMERICA: MICROFLUIDIC INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 158 TABLE 69 EUROPE: MICROFLUIDIC INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 70 ASIA PACIFIC: MICROFLUIDIC INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 71 LATIN AMERICA: MICROFLUIDIC INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 72 MIDDLE EAST: MICROFLUIDIC INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 160 TABLE 73 GCC COUNTRIES: MICROFLUIDIC INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 74 CELL SORTERS MARKET, BY REGION, 2023–2030 (USD MILLION) 161 TABLE 75 NORTH AMERICA: CELL SORTERS MARKET, 2023–2030 (USD MILLION) 161 TABLE 76 EUROPE: CELL SORTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 77 ASIA PACIFIC: CELL SORTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 78 LATIN AMERICA: CELL SORTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 79 MIDDLE EAST: CELL SORTERS MARKET, BY REGION, 2023–2030 (USD MILLION) 163 TABLE 80 GCC COUNTRIES: CELL SORTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 81 PCR INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 164 TABLE 82 NORTH AMERICA: PCR INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 164 TABLE 83 EUROPE: PCR INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 84 ASIA PACIFIC: PCR INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 85 LATIN AMERICA: PCR INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 86 MIDDLE EAST: PCR INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 166 TABLE 87 GCC COUNTRIES: PCR INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 88 LCM INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 167 TABLE 89 NORTH AMERICA: LCM INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 167 TABLE 90 EUROPE: LCM INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 91 ASIA PACIFIC: LCM INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 92 LATIN AMERICA: LCM INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 93 MIDDLE EAST: LCM INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 169 TABLE 94 GCC COUNTRIES: LCM INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 95 OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 170 TABLE 96 NORTH AMERICA: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 170 TABLE 97 EUROPE: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 98 ASIA PACIFIC: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 99 LATIN AMERICA: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 172 TABLE 100 MIDDLE EAST: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 172 TABLE 101 GCC COUNTRIES: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 172 TABLE 102 SEQUENCING PLATFORMS MARKET, BY TYPE, 2023–2030 (UNITS) 173 TABLE 103 SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 174 TABLE 104 NORTH AMERICA: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 174 TABLE 105 EUROPE: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 175 TABLE 106 ASIA PACIFIC: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 175 TABLE 107 LATIN AMERICA: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 108 MIDDLE EAST: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 176 TABLE 109 GCC COUNTRIES: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 110 SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION) 177 TABLE 111 NORTH AMERICA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 177 TABLE 112 EUROPE: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 113 ASIA PACIFIC: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 114 LATIN AMERICA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 179 TABLE 115 MIDDLE EAST: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION) 179 TABLE 116 GCC COUNTRIES: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 179 TABLE 117 SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 118 SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY REGION, 2023–2030 (USD MILLION) 180 TABLE 119 NORTH AMERICA: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 120 EUROPE: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 121 ASIA PACIFIC: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 122 LATIN AMERICA: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 123 MIDDLE EAST: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY REGION, 2023–2030 (USD MILLION) 182 TABLE 124 GCC COUNTRIES: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 183 TABLE 125 SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION) 184 TABLE 126 NORTH AMERICA: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 184 TABLE 127 EUROPE: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, 2023–2030 (USD MILLION) 185 TABLE 128 ASIA PACIFIC: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 185 TABLE 129 LATIN AMERICA: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 186 TABLE 130 MIDDLE EAST: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION) 186 TABLE 131 GCC COUNTRIES: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 186 TABLE 132 SINGLE-CELL SEQUENCING PRODUCT MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 188 TABLE 133 PRE-SEQUENCING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 189 TABLE 134 NORTH AMERICA: PRE-SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 135 EUROPE: PRE-SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 190 TABLE 136 ASIA PACIFIC: PRE-SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 190 TABLE 137 LATIN AMERICA: PRE-SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 138 MIDDLE EAST: PRE-SEQUENCING PRODUCT MARKET, BY REGION, 2023–2030 (USD MILLION) 191 TABLE 139 GCC COUNTRIES: PRE-SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 140 SEQUENCING PRODUCT MARKET, BY REGION, 2023–2030 (USD MILLION) 192 TABLE 141 NORTH AMERICA: SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 142 EUROPE: SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 143 ASIA PACIFIC: SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 144 LATIN AMERICA: SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 145 MIDDLE EAST: SEQUENCING PRODUCT MARKET, BY REGION, 2023–2030 (USD MILLION) 195 TABLE 146 GCC COUNTRIES: SEQUENCING PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 195 TABLE 147 DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY REGION, 2023–2030 (USD MILLION) 196 TABLE 148 NORTH AMERICA: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 196 TABLE 149 EUROPE: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 197 TABLE 150 ASIA PACIFIC: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 197 TABLE 151 LATIN AMERICA: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 198 TABLE 152 MIDDLE EAST: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY REGION, 2023–2030 (USD MILLION) 198 TABLE 153 GCC COUNTRIES: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 198 TABLE 154 SINGLE-CELL SEQUENCING PRODUCT MARKET, BY END USER, 2023–2030 (USD MILLION) 200 TABLE 155 SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 201 TABLE 156 NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 201 TABLE 157 EUROPE: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 202 TABLE 158 ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 202 TABLE 159 LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 203 TABLE 160 MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 203 TABLE 161 GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 203 TABLE 162 SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 204 TABLE 163 NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 205 TABLE 164 EUROPE: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 205 TABLE 165 ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 206 TABLE 166 LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 206 TABLE 167 MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 206 TABLE 168 GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 207 TABLE 169 SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2023–2030 (USD MILLION) 208 TABLE 170 NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 208 TABLE 171 EUROPE: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 209 TABLE 172 ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 209 TABLE 173 LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 210 TABLE 174 MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2023–2030 (USD MILLION) 210 TABLE 175 GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 210 TABLE 176 SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2023–2030 (USD MILLION) 211 TABLE 177 NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 212 TABLE 178 EUROPE: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 212 TABLE 179 ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 213 TABLE 180 LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 213 TABLE 181 MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2023–2030 (USD MILLION) 213 TABLE 182 GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 214 TABLE 183 SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 216 TABLE 184 PRE-SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 217 TABLE 185 NORTH AMERICA: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 217 TABLE 186 EUROPE: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 218 TABLE 187 ASIA PACIFIC: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 218 TABLE 188 LATIN AMERICA: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 219 TABLE 189 MIDDLE EAST: PRE-SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 219 TABLE 190 GCC COUNTRIES: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 219 TABLE 191 PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 220 TABLE 192 SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 221 TABLE 193 NORTH AMERICA: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 221 TABLE 194 EUROPE: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 222 TABLE 195 ASIA PACIFIC: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 222 TABLE 196 LATIN AMERICA: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 223 TABLE 197 MIDDLE EAST: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 223 TABLE 198 GCC COUNTRIES: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 223 TABLE 199 LIBRARY PREPARATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 224 TABLE 200 NORTH AMERICA: LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 225 TABLE 201 EUROPE: LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 225 TABLE 202 ASIA PACIFIC: LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 226 TABLE 203 LATIN AMERICA: LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 226 TABLE 204 MIDDLE EAST: LIBRARY PREPARATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 227 TABLE 205 GCC COUNTRIES: LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 227 TABLE 206 SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 228 TABLE 207 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 228 TABLE 208 EUROPE: SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 229 TABLE 209 ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 229 TABLE 210 LATIN AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 230 TABLE 211 MIDDLE EAST: SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 230 TABLE 212 GCC COUNTRIES: SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 230 TABLE 213 DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 231 TABLE 214 NORTH AMERICA: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 232 TABLE 215 EUROPE: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 232 TABLE 216 ASIA PACIFIC: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 233 TABLE 217 LATIN AMERICA: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 233 TABLE 218 MIDDLE EAST: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 234 TABLE 219 GCC COUNTRIES: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 234 TABLE 220 SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 236 TABLE 221 SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 237 TABLE 222 NORTH AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 237 TABLE 223 EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 238 TABLE 224 ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 238 TABLE 225 LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 239 TABLE 226 MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 239 TABLE 227 GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 239 TABLE 228 SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 240 TABLE 229 NORTH AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 241 TABLE 230 EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 241 TABLE 231 ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 242 TABLE 232 LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 242 TABLE 233 MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 242 TABLE 234 GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 243 TABLE 235 SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2023–2030 (USD MILLION) 244 TABLE 236 NORTH AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 244 TABLE 237 EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 245 TABLE 238 ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 245 TABLE 239 LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 246 TABLE 240 MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2023–2030 (USD MILLION) 246 TABLE 241 GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 246 TABLE 242 SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 248 TABLE 243 SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION) 249 TABLE 244 NORTH AMERICA: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 249 TABLE 245 EUROPE: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 250 TABLE 246 ASIA PACIFIC: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 250 TABLE 247 LATIN AMERICA: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 251 TABLE 248 MIDDLE EAST: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION) 251 TABLE 249 GCC COUNTRIES: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 251 TABLE 250 SINGLE-CELL GENOME SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION) 252 TABLE 251 NORTH AMERICA: SINGLE-CELL GENOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 253 TABLE 252 EUROPE: SINGLE-CELL GENOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 253 TABLE 253 ASIA PACIFIC: SINGLE-CELL GENOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 254 TABLE 254 LATIN AMERICA: SINGLE-CELL GENOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 254 TABLE 255 MIDDLE EAST: SINGLE-CELL GENOME SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION) 255 TABLE 256 GCC COUNTRIES: SINGLE-CELL GENOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 255 TABLE 257 SINGLE-CELL ATAC SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION) 256 TABLE 258 NORTH AMERICA: SINGLE-CELL ATAC SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 256 TABLE 259 EUROPE: SINGLE-CELL ATAC SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 257 TABLE 260 ASIA PACIFIC: SINGLE-CELL ATAC SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 257 TABLE 261 LATIN AMERICA: SINGLE-CELL ATAC SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 258 TABLE 262 MIDDLE EAST: SINGLE-CELL ATAC SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION) 258 TABLE 263 GCC COUNTRIES: SINGLE-CELL ATAC SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 258 TABLE 264 OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY REGION, 2023–2030 (USD MILLION) 259 TABLE 265 NORTH AMERICA: OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 260 TABLE 266 EUROPE: OTHER SINGLE-CELL SEQUENCING TYPES MARKET, 2023–2030 (USD MILLION) 260 TABLE 267 ASIA PACIFIC: OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 261 TABLE 268 LATIN AMERICA: OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 261 TABLE 269 MIDDLE EAST: OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY REGION, 2023–2030 (USD MILLION) 262 TABLE 270 GCC COUNTRIES: OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 262 TABLE 271 SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 264 TABLE 272 SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 265 TABLE 273 SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATIONAL RESEARCH, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 274 SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY REGION, 2023–2030 (USD MILLION) 267 TABLE 275 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 267 TABLE 276 EUROPE: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 268 TABLE 277 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 268 TABLE 278 LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 269 TABLE 279 MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY REGION, 2023–2030 (USD MILLION) 269 TABLE 280 GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 269 TABLE 281 SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY REGION, 2023–2030 (USD MILLION) 270 TABLE 282 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 271 TABLE 283 EUROPE: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 271 TABLE 284 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 272 TABLE 285 LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 272 TABLE 286 MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY REGION, 2023–2030 (USD MILLION) 273 TABLE 287 GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 273 TABLE 288 SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY REGION, 2023–2030 (USD MILLION) 274 TABLE 289 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 274 TABLE 290 EUROPE: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 275 TABLE 291 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 275 TABLE 292 LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 276 TABLE 293 MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY REGION, 2023–2030 (USD MILLION) 276 TABLE 294 GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 276 TABLE 295 SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY REGION, 2023–2030 (USD MILLION) 277 TABLE 296 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 278 TABLE 297 EUROPE: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 278 TABLE 298 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 279 TABLE 299 LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 279 TABLE 300 MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY REGION, 2023–2030 (USD MILLION) 279 TABLE 301 GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 280 TABLE 302 SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY REGION, 2023–2030 (USD MILLION) 280 TABLE 303 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION) 281 TABLE 304 EUROPE: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION) 281 TABLE 305 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION) 282 TABLE 306 LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION) 282 TABLE 307 MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY REGION, 2023–2030 (USD MILLION) 282 TABLE 308 GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION) 283 TABLE 309 SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2023–2030 (USD MILLION) 284 TABLE 310 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 284 TABLE 311 EUROPE: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 285 TABLE 312 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 285 TABLE 313 LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 286 TABLE 314 MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2023–2030 (USD MILLION) 286 TABLE 315 GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 286 TABLE 316 SINGLE-CELL SEQUENCING MARKET FOR DIAGNOSTIC & CLINICAL APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 287 TABLE 317 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR DIAGNOSTIC & CLINICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 288 TABLE 318 EUROPE: SINGLE-CELL SEQUENCING MARKET FOR DIAGNOSTIC & CLINICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 288 TABLE 319 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR DIAGNOSTIC & CLINICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 289 TABLE 320 LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR DIAGNOSTIC & CLINICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 289 TABLE 321 MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR DIAGNOSTIC & CLINICAL APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 289 TABLE 322 GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR DIAGNOSTIC & CLINICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 290 TABLE 323 SINGLE-CELL SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION) 292 TABLE 324 NORTH AMERICA: MACROECONOMIC INDICATORS 293 TABLE 325 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 294 TABLE 326 NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 295 TABLE 327 NORTH AMERICA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 295 TABLE 328 NORTH AMERICA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 295 TABLE 329 NORTH AMERICA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 296 TABLE 330 NORTH AMERICA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 296 TABLE 331 NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 297 TABLE 332 NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 297 TABLE 333 NORTH AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 298 TABLE 334 NORTH AMERICA: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 298 TABLE 335 NORTH AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 299 TABLE 336 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 299 TABLE 337 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 300 TABLE 338 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 300 TABLE 339 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 301 TABLE 340 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 301 TABLE 341 US: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 302 TABLE 342 US: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 303 TABLE 343 US: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 303 TABLE 344 US: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 303 TABLE 345 US: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 304 TABLE 346 US: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 304 TABLE 347 US: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 304 TABLE 348 US: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 305 TABLE 349 US: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 305 TABLE 350 US: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 306 TABLE 351 US: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 306 TABLE 352 US: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 307 TABLE 353 US: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 307 TABLE 354 US: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 307 TABLE 355 US: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 308 TABLE 356 CANADA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 309 TABLE 357 CANADA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 309 TABLE 358 CANADA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 309 TABLE 359 CANADA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 310 TABLE 360 CANADA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 310 TABLE 361 CANADA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 310 TABLE 362 CANADA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 311 TABLE 363 CANADA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 311 TABLE 364 CANADA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 312 TABLE 365 CANADA: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 312 TABLE 366 CANADA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 313 TABLE 367 CANADA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 313 TABLE 368 CANADA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 314 TABLE 369 CANADA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 314 TABLE 370 CANADA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 315 TABLE 371 EUROPE: MACROECONOMIC INDICATORS 316 TABLE 372 EUROPE: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 317 TABLE 373 EUROPE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2 023–2030 (USD MILLION) 317 TABLE 374 EUROPE: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 317 TABLE 375 EUROPE: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 318 TABLE 376 EUROPE: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 318 TABLE 377 EUROPE: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 318 TABLE 378 EUROPE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 319 TABLE 379 EUROPE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 319 TABLE 380 EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 320 TABLE 381 EUROPE: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 320 TABLE 382 EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 321 TABLE 383 EUROPE: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 321 TABLE 384 EUROPE: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 322 TABLE 385 EUROPE: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 322 TABLE 386 EUROPE: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 323 TABLE 387 EUROPE: SINGLE-CELL SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 323 TABLE 388 GERMANY: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 324 TABLE 389 GERMANY: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 324 TABLE 390 GERMANY: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 325 TABLE 391 GERMANY: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 325 TABLE 392 GERMANY: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 325 TABLE 393 GERMANY: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 326 TABLE 394 GERMANY: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 326 TABLE 395 GERMANY: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 327 TABLE 396 GERMANY: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 327 TABLE 397 GERMANY: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 328 TABLE 398 GERMANY: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 328 TABLE 399 GERMANY: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 329 TABLE 400 GERMANY: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 329 TABLE 401 GERMANY: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 329 TABLE 402 GERMANY: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 330 TABLE 403 UK: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 331 TABLE 404 UK: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 331 TABLE 405 UK: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 331 TABLE 406 UK: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 332 TABLE 407 UK: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 332 TABLE 408 UK: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 332 TABLE 409 UK: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 333 TABLE 410 UK: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 333 TABLE 411 UK: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 334 TABLE 412 UK: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 334 TABLE 413 UK: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 335 TABLE 414 UK: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 335 TABLE 415 UK: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 336 TABLE 416 UK: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 336 TABLE 417 UK: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 337 TABLE 418 FRANCE: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 338 TABLE 419 FRANCE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 338 TABLE 420 FRANCE: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 338 TABLE 421 FRANCE: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 339 TABLE 422 FRANCE: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 339 TABLE 423 FRANCE: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 339 TABLE 424 FRANCE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 340 TABLE 425 FRANCE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 340 TABLE 426 FRANCE: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 341 TABLE 427 FRANCE: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 341 TABLE 428 FRANCE: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 342 TABLE 429 FRANCE: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 342 TABLE 430 FRANCE: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 343 TABLE 431 FRANCE: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 343 TABLE 432 FRANCE: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 344 TABLE 433 ITALY: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 345 TABLE 434 ITALY: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 345 TABLE 435 ITALY: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 345 TABLE 436 ITALY: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 346 TABLE 437 ITALY: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 346 TABLE 438 ITALY: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 346 TABLE 439 ITALY: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 347 TABLE 440 ITALY: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 347 TABLE 441 ITALY: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 348 TABLE 442 ITALY: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 348 TABLE 443 ITALY: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 349 TABLE 444 ITALY: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 349 TABLE 445 ITALY: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 349 TABLE 446 ITALY: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 350 TABLE 447 ITALY: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 350 TABLE 448 SPAIN: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 351 TABLE 449 SPAIN: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 351 TABLE 450 SPAIN: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 352 TABLE 451 SPAIN: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 352 TABLE 452 SPAIN: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 352 TABLE 453 SPAIN: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 353 TABLE 454 SPAIN: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 353 TABLE 455 SPAIN: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 354 TABLE 456 SPAIN: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 354 TABLE 457 SPAIN: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 355 TABLE 458 SPAIN: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 355 TABLE 459 SPAIN: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 356 TABLE 460 SPAIN: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 356 TABLE 461 SPAIN: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 356 TABLE 462 SPAIN: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 357 TABLE 463 REST OF EUROPE: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 357 TABLE 464 REST OF EUROPE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 358 TABLE 465 REST OF EUROPE: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 358 TABLE 466 REST OF EUROPE: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 358 TABLE 467 REST OF EUROPE: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 359 TABLE 468 REST OF EUROPE: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 359 TABLE 469 REST OF EUROPE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 360 TABLE 470 REST OF EUROPE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 360 TABLE 471 REST OF EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 361 TABLE 472 REST OF EUROPE: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 361 TABLE 473 REST OF EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 362 TABLE 474 REST OF EUROPE: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 362 TABLE 475 REST OF EUROPE: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 363 TABLE 476 REST OF EUROPE: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 363 TABLE 477 REST OF EUROPE: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 364 TABLE 478 ASIA PACIFIC: MACROECONOMIC INDICATORS 365 TABLE 479 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 366 TABLE 480 ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 367 TABLE 481 ASIA PACIFIC: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 367 TABLE 482 ASIA PACIFIC: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 367 TABLE 483 ASIA PACIFIC: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 368 TABLE 484 ASIA PACIFIC: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 368 TABLE 485 ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 368 TABLE 486 ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 369 TABLE 487 ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 369 TABLE 488 SIA PACIFIC: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 370 TABLE 489 ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 370 TABLE 490 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 371 TABLE 491 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 371 TABLE 492 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 371 TABLE 493 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 372 TABLE 494 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 372 TABLE 495 CHINA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 373 TABLE 496 CHINA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 373 TABLE 497 CHINA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 374 TABLE 498 CHINA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 374 TABLE 499 CHINA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 374 TABLE 500 CHINA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 375 TABLE 501 CHINA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 375 TABLE 502 CHINA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 376 TABLE 503 CHINA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 376 TABLE 504 CHINA: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 377 TABLE 505 CHINA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 377 TABLE 506 CHINA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 378 TABLE 507 CHINA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 378 TABLE 508 CHINA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 378 TABLE 509 CHINA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 379 TABLE 510 JAPAN: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 380 TABLE 511 JAPAN: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 380 TABLE 512 JAPAN: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 380 TABLE 513 JAPAN: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 381 TABLE 514 JAPAN: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 381 TABLE 515 JAPAN: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 381 TABLE 516 JAPAN: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 382 TABLE 517 JAPAN: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 382 TABLE 518 JAPAN: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 383 TABLE 519 JAPAN: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 383 TABLE 520 JAPAN: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 384 TABLE 521 JAPAN: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 384 TABLE 522 JAPAN: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 385 TABLE 523 JAPAN: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 385 TABLE 524 JAPAN: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 386 TABLE 525 INDIA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 387 TABLE 526 INDIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 387 TABLE 527 INDIA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 387 TABLE 528 INDIA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 388 TABLE 529 INDIA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 388 TABLE 530 INDIA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 388 TABLE 531 INDIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 389 TABLE 532 INDIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 389 TABLE 533 INDIA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 390 TABLE 534 INDIA: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 390 TABLE 535 INDIA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 391 TABLE 536 INDIA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 391 TABLE 537 INDIA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 392 TABLE 538 INDIA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 392 TABLE 539 INDIA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 393 TABLE 540 SOUTH KOREA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 394 TABLE 541 SOUTH KOREA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 394 TABLE 542 SOUTH KOREA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 394 TABLE 543 SOUTH KOREA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 395 TABLE 544 SOUTH KOREA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 395 TABLE 545 SOUTH KOREA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 395 TABLE 546 SOUTH KOREA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 396 TABLE 547 SOUTH KOREA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 396 TABLE 548 SOUTH KOREA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 397 TABLE 549 SOUTH KOREA: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 397 TABLE 550 SOUTH KOREA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 398 TABLE 551 SOUTH KOREA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 398 TABLE 552 SOUTH KOREA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 399 TABLE 553 SOUTH KOREA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 399 TABLE 554 SOUTH KOREA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 400 TABLE 555 AUSTRALIA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 401 TABLE 556 AUSTRALIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 401 TABLE 557 AUSTRALIA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 401 TABLE 558 AUSTRALIA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 402 TABLE 559 AUSTRALIA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 402 TABLE 560 AUSTRALIA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 402 TABLE 561 AUSTRALIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 403 TABLE 562 AUSTRALIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 403 TABLE 563 AUSTRALIA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 404 TABLE 564 AUSTRALIA: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 404 TABLE 565 AUSTRALIA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 405 TABLE 566 AUSTRALIA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 405 TABLE 567 AUSTRALIA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 406 TABLE 568 AUSTRALIA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 406 TABLE 569 AUSTRALIA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 407 TABLE 570 REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 408 TABLE 571 REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 408 TABLE 572 REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 408 TABLE 573 REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 409 TABLE 574 REST OF ASIA PACIFIC: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 409 TABLE 575 REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 409 TABLE 576 REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 410 TABLE 577 REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 410 TABLE 578 REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 411 TABLE 579 REST OF ASIA PACIFIC: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 411 TABLE 580 REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 412 TABLE 581 REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 412 TABLE 582 REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 413 TABLE 583 REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 413 TABLE 584 REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 414 TABLE 585 LATIN AMERICA: MACROECONOMIC INDICATORS 415 TABLE 586 LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 415 TABLE 587 LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 415 TABLE 588 LATIN AMERICA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 416 TABLE 589 LATIN AMERICA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 416 TABLE 590 LATIN AMERICA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 416 TABLE 591 LATIN AMERICA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 417 TABLE 592 LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 417 TABLE 593 LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 418 TABLE 594 LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 418 TABLE 595 LATIN AMERICA: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 419 TABLE 596 LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 419 TABLE 597 LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 420 TABLE 598 LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 420 TABLE 599 LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 420 TABLE 600 LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 421 TABLE 601 LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 421 TABLE 602 BRAZIL: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 422 TABLE 603 BRAZIL: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 422 TABLE 604 BRAZIL: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 423 TABLE 605 BRAZIL: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 423 TABLE 606 BRAZIL: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 423 TABLE 607 BRAZIL: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 424 TABLE 608 BRAZIL: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 424 TABLE 609 BRAZIL: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 425 TABLE 610 BRAZIL: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 425 TABLE 611 BRAZIL: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 426 TABLE 612 BRAZIL: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 426 TABLE 613 BRAZIL: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 427 TABLE 614 BRAZIL: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 427 TABLE 615 BRAZIL: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 427 TABLE 616 BRAZIL: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 428 TABLE 617 MEXICO: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 429 TABLE 618 MEXICO: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 429 TABLE 619 MEXICO: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 429 TABLE 620 MEXICO: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 430 TABLE 621 MEXICO: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 430 TABLE 622 MEXICO: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 430 TABLE 623 MEXICO: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 431 TABLE 624 MEXICO: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 431 TABLE 625 MEXICO: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 432 TABLE 626 MEXICO: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 432 TABLE 627 MEXICO: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 433 TABLE 628 MEXICO: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 433 TABLE 629 MEXICO: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 434 TABLE 630 MEXICO: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 434 TABLE 631 MEXICO: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 435 TABLE 632 REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 436 TABLE 633 REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 436 TABLE 634 REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 436 TABLE 635 REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 437 TABLE 636 REST OF LATIN AMERICA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 437 TABLE 637 REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 437 TABLE 638 REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 438 TABLE 639 REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 438 TABLE 640 REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 439 TABLE 641 REST OF LATIN AMERICA: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 439 TABLE 642 REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 440 TABLE 643 REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 440 TABLE 644 REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 441 TABLE 645 REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 441 TABLE 646 REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 442 TABLE 647 MIDDLE EAST: MACROECONOMIC INDICATORS 443 TABLE 648 MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 443 TABLE 649 MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 444 TABLE 650 MIDDLE EAST: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 444 TABLE 651 MIDDLE EAST: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 444 TABLE 652 MIDDLE EAST: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 445 TABLE 653 MIDDLE EAST: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 445 TABLE 654 MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 446 TABLE 655 MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 446 TABLE 656 MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 447 TABLE 657 MIDDLE EAST: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 447 TABLE 658 MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 448 TABLE 659 MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 448 TABLE 660 MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 449 TABLE 661 MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 449 TABLE 662 MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 450 TABLE 663 MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION) 450 TABLE 664 GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 451 TABLE 665 GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 451 TABLE 666 GCC COUNTRIES: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 451 TABLE 667 GCC COUNTRIES: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 452 TABLE 668 GCC COUNTRIES: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 452 TABLE 669 GCC COUNTRIES: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 452 TABLE 670 GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 453 TABLE 671 GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 453 TABLE 672 GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 454 TABLE 673 GCC COUNTRIES: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 454 TABLE 674 GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 455 TABLE 675 GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 455 TABLE 676 GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 456 TABLE 677 GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 456 TABLE 678 GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 457 TABLE 679 GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 457 TABLE 680 KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 458 TABLE 681 KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 458 TABLE 682 KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 459 TABLE 683 KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 459 TABLE 684 KINGDOM OF SAUDI ARABIA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 459 TABLE 685 KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 460 TABLE 686 KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 460 TABLE 687 KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 461 TABLE 688 KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 461 TABLE 689 KINGDOM OF SAUDI ARABIA: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 462 TABLE 690 KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 462 TABLE 691 KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 463 TABLE 692 KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 463 TABLE 693 KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 463 TABLE 694 KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 464 TABLE 695 UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 465 TABLE 696 UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 465 TABLE 697 UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 465 TABLE 698 UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 466 TABLE 699 UNITED ARAB EMIRATES: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 466 TABLE 700 UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 466 TABLE 701 UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 467 TABLE 702 UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 467 TABLE 703 UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 468 TABLE 704 UNITED ARAB EMIRATES: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 468 TABLE 705 UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 469 TABLE 706 UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 469 TABLE 707 UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 470 TABLE 708 UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 470 TABLE 709 UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 471 TABLE 710 OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 471 TABLE 711 OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 472 TABLE 712 OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 472 TABLE 713 OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 472 TABLE 714 OTHER GCC COUNTRIES: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 473 TABLE 715 OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 473 TABLE 716 OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 474 TABLE 717 OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 474 TABLE 718 OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 475 TABLE 719 OTHER GCC COUNTRIES: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 475 TABLE 720 OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 476 TABLE 721 OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 476 TABLE 722 OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 477 TABLE 723 OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 477 TABLE 724 OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 478 TABLE 725 REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 479 TABLE 726 REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 479 TABLE 727 REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 479 TABLE 728 REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 480 TABLE 729 REST OF MIDDLE EAST: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 480 TABLE 730 REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 480 TABLE 731 REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 481 TABLE 732 REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 481 TABLE 733 REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 482 TABLE 734 REST OF MIDDLE EAST: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 482 TABLE 735 REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 483 TABLE 736 REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 483 TABLE 737 REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 484 TABLE 738 REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 484 TABLE 739 REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 485 TABLE 740 MACROECONOMIC OUTLOOK FOR AFRICA 486 TABLE 741 AFRICA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 486 TABLE 742 AFRICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 487 TABLE 743 AFRICA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 487 TABLE 744 AFRICA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 487 TABLE 745 AFRICA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 488 TABLE 746 AFRICA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 488 TABLE 747 AFRICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 488 TABLE 748 AFRICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 489 TABLE 749 AFRICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 489 TABLE 750 AFRICA: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 490 TABLE 751 AFRICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 490 TABLE 752 AFRICA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION) 491 TABLE 753 AFRICA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 491 TABLE 754 AFRICA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 491 TABLE 755 AFRICA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 492 TABLE 756 SINGLE-CELL SEQUENCING MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2021–2025 493 TABLE 757 SINGLE-CELL SEQUENCING MARKET: DEGREE OF COMPETITION 498 TABLE 758 SINGLE-CELL SEQUENCING PRODUCT MARKET: REGION FOOTPRINT 503 TABLE 759 SINGLE-CELL SEQUENCING PRODUCT MARKET: PRODUCT TYPE FOOTPRINT 504 TABLE 760 SINGLE-CELL SEQUENCING PRODUCT MARKET: WORKFLOW FOOTPRINT 505 TABLE 761 SINGLE-CELL SEQUENCING PRODUCT MARKET: APPLICATION FOOTPRINT 507 TABLE 762 SINGLE-CELL SEQUENCING SERVICE MARKET: REGION FOOTPRINT 511 TABLE 763 SINGLE-CELL SEQUENCING SERVICE MARKET: SERVICE TYPE FOOTPRINT 512 TABLE 764 SINGLE-CELL SEQUENCING SERVICE MARKET: APPLICATION FOOTPRINT 512 TABLE 765 SINGLE-CELL SEQUENCING MARKET: DETAILED LIST OF KEY STARTUPS/SMES 515 TABLE 766 SINGLE-CELL SEQUENCING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 517 TABLE 767 SINGLE-CELL SEQUENCING MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2021–JULY 2025 520 TABLE 768 SINGLE-CELL SEQUENCING MARKET: DEALS, JANUARY 2021–JULY 2025 522 TABLE 769 BD: COMPANY OVERVIEW 525 TABLE 770 BD: PRODUCTS OFFERED 526 TABLE 771 BD: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 527 TABLE 772 BD: DEALS, JANUARY 2021–JULY 2025 529 TABLE 773 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 531 TABLE 774 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 532 TABLE 775 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 534 TABLE 776 DANAHER CORPORATION: COMPANY OVERVIEW 536 TABLE 777 DANAHER CORPORATION: PRODUCTS OFFERED 537 TABLE 778 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 539 TABLE 779 DANAHER CORPORATION: DEALS, JANUARY 2021–JULY 2025 540 TABLE 780 10X GENOMICS: COMPANY OVERVIEW 541 TABLE 781 10X GENOMICS: PRODUCTS OFFERED 542 TABLE 782 10X GENOMICS: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 544 TABLE 783 10X GENOMICS: DEALS, JANUARY 2021–APRIL 2025 545 TABLE 784 ILLUMINA, INC.: COMPANY OVERVIEW 548 TABLE 785 ILLUMINA, INC.: PRODUCTS OFFERED 549 TABLE 786 ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 551 TABLE 787 ILLUMINA, INC.: DEALS, JANUARY 2021–APRIL 2025 552 TABLE 788 MERCK KGAA: COMPANY OVERVIEW 554 TABLE 789 MERCK KGAA: PRODUCTS OFFERED 556 TABLE 790 QIAGEN N.V.: COMPANY OVERVIEW 558 TABLE 791 QIAGEN N.V.: PRODUCTS OFFERED 560 TABLE 792 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 561 TABLE 793 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 562 TABLE 794 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 564 TABLE 795 TECAN TRADING AG: COMPANY OVERVIEW 565 TABLE 796 TECAN TRADING AG: PRODUCTS OFFERED 566 TABLE 797 TECAN TRADING AG: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 567 TABLE 798 TECAN TRADING AG: DEALS, JANUARY 2021–JULY 2025 568 TABLE 799 CYTEK BIOSCIENCES: COMPANY OVERVIEW 569 TABLE 800 CYTEK BIOSCIENCES: PRODUCTS OFFERED 570 TABLE 801 CYTEK BIOSCIENCES: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 570 TABLE 802 CYTEK BIOSCIENCES: DEALS, JANUARY 2021–JULY 2025 570 TABLE 803 CYTEK BIOSCIENCES: EXPANSIONS, JANUARY 2021–JULY 2025 571 TABLE 804 TAKARA BIO INC.: COMPANY OVERVIEW 572 TABLE 805 TAKARA BIO INC.: PRODUCTS OFFERED 573 TABLE 806 TAKARA BIO INC.: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 575 TABLE 807 TAKARA BIO INC.: DEALS, JANUARY 2021–JULY 2025 575 TABLE 808 BIO-TECHNE: COMPANY OVERVIEW 576 TABLE 809 BIO-TECHNE: PRODUCTS OFFERED 577 TABLE 810 BIO-TECHNE: DEALS, JANUARY 2021–JULY 2025 578 TABLE 811 PACBIO: COMPANY OVERVIEW 579 TABLE 812 PACBIO: PRODUCTS OFFERED 580 TABLE 813 PACBIO: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 581 TABLE 814 AZENTA US INC.: COMPANY OVERVIEW 582 TABLE 815 AZENTA US INC.: SERVICES OFFERED 583 TABLE 816 NOVOGENE CO., LTD.: COMPANY OVERVIEW 585 TABLE 817 NOVOGENE CO., LTD.: SERVICES OFFERED 585 TABLE 818 NOVOGENE CO., LTD.: SERVICE LAUNCHES, JANUARY 2021–JULY 2025 586 TABLE 819 NOVOGENE CO., LTD.: EXPANSIONS, JANUARY 2021–JULY 2025 586 TABLE 820 IQVIA INC.: COMPANY OVERVIEW 588 TABLE 821 IQVIA INC.: SERVICES OFFERED 589 TABLE 822 ALMAC GROUP: COMPANY OVERVIEW 590 TABLE 823 ALMAC GROUP: SERVICES OFFERED 590 TABLE 824 CEGAT GMBH: COMPANY OVERVIEW 591 TABLE 825 CEGAT GMBH: SERVICES OFFERED 591 TABLE 826 ACTIVE MOTIF: COMPANY OVERVIEW 592 TABLE 827 ACTIVE MOTIF: SERVICES OFFERED 592 TABLE 828 SINGLERON BIOTECHNOLOGIES: COMPANY OVERVIEW 593 TABLE 829 CELL MICROSYSTEMS: COMPANY OVERVIEW 594 TABLE 830 NANOCELLECT BIOMEDICAL: COMPANY OVERVIEW 595 TABLE 831 OXFORD NANOPORE TECHNOLOGIES PLC.: COMPANY OVERVIEW 596 TABLE 832 REVVITY: COMPANY OVERVIEW 597 TABLE 833 PARSE BIOSCIENCES: COMPANY OVERVIEW 598 TABLE 834 ULTIMA GENOMICS: COMPANY OVERVIEW 599 TABLE 835 MISSION BIO: BUSINESS OVERVIEW 600 TABLE 836 SINGLE CELL DISCOVERIES BV: COMPANY OVERVIEW 601 TABLE 837 ADMERA HEALTH: COMPANY OVERVIEW 602 TABLE 838 BGI: COMPANY OVERVIEW 603 TABLE 839 SIGNIOSBIO: COMPANY OVERVIEW 604 TABLE 840 MACROGEN CO., LTD.: COMPANY OVERVIEW 605 TABLE 841 LEXOGEN GMBH: COMPANY OVERVIEW 606 TABLE 842 DISCOVERY LIFE SCIENCES: COMPANY OVERVIEW 607 TABLE 843 CELLCARTA: COMPANY OVERVIEW 608 TABLE 844 SINGULOMICS CORPORATION: COMPANY OVERVIEW 609 TABLE 845 SEQMATIC LLC.: COMPANY OVERVIEW 610 FIGURE 1 SINGLE-CELL SEQUENCING MARKET: MARKETS & REGIONS COVERED 53 FIGURE 2 REGIONAL SEGMENTATION 54 FIGURE 3 YEARS CONSIDERED 56 FIGURE 4 RESEARCH DESIGN METHODOLOGY 57 FIGURE 5 SINGLE-CELL SEQUENCING MARKET: BREAKDOWN OF PRIMARY INTERVIEWS 59 FIGURE 6 SINGLE-CELL SEQUENCING MARKET SIZE ESTIMATION, 2024 60 FIGURE 7 GLOBAL MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH), 2024 61 FIGURE 8 ILLUSTRATIVE EXAMPLE OF 10X GENOMICS: REVENUE ANALYSIS (2024) 61 FIGURE 9 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 63 FIGURE 10 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 63 FIGURE 11 SINGLE-CELL SEQUENCING MARKET: CAGR PROJECTIONS, 2025−2030 66 FIGURE 12 SINGLE-CELL SEQUENCING MARKET: GROWTH ANALYSIS OF MARKET DYNAMICS 67 FIGURE 13 DATA TRIANGULATION METHODOLOGY 69 FIGURE 14 SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION) 72 FIGURE 15 SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 73 FIGURE 16 SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2024 73 FIGURE 17 SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 74 FIGURE 18 SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 75 FIGURE 19 SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2025 VS. 2030 (USD MILLION) 75 FIGURE 20 SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 76 FIGURE 21 SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 77 FIGURE 22 GEOGRAPHIC SNAPSHOT OF SINGLE-CELL SEQUENCING MARKET 78 FIGURE 23 ADVANCEMENTS IN SINGLE-CELL SEQUENCING TECHNOLOGIES TO PROPEL MARKET 81 FIGURE 24 PRODUCTS SEGMENT IN US ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 82 FIGURE 25 CANCER RESEARCH APPLICATIONS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 82 FIGURE 26 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 83 FIGURE 27 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 83 FIGURE 28 ASIA PACIFIC REGION TO DOMINATE MARKET DURING FORECAST PERIOD 84 FIGURE 29 SINGLE-CELL SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 85 FIGURE 30 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 94 FIGURE 31 SINGLE-CELL SEQUENCING MARKET: VALUE CHAIN ANALYSIS 95 FIGURE 32 SINGLE-CELL SEQUENCING MARKET: ECOSYSTEM ANALYSIS 96 FIGURE 33 PATENT APPLICATIONS IN SINGLE-CELL SEQUENCING MARKET, JANUARY 2014–DECEMBER 2024 102 FIGURE 34 SINGLE-CELL SEQUENCING MARKET: PORTER’S FIVE FORCES ANALYSIS 108 FIGURE 35 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2022–2024 119 FIGURE 36 AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2024 120 FIGURE 37 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR SINGLE-CELL SEQUENCING PRODUCTS 121 FIGURE 38 KEY BUYING CRITERIA FOR END USERS 123 FIGURE 39 AI-USE CASES 128 FIGURE 40 NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET SNAPSHOT 294 FIGURE 41 NIH FUNDING FOR STEM CELL RESEARCH, 2015–2025 302 FIGURE 42 ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET SNAPSHOT 366 FIGURE 43 REVENUE ANALYSIS OF KEY PLAYERS IN SINGLE-CELL SEQUENCING MARKET, 2022–2024 496 FIGURE 44 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 497 FIGURE 45 SINGLE-CELL SEQUENCING PRODUCTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 501 FIGURE 46 SINGLE-CELL SEQUENCING PRODUCT MARKET: COMPANY FOOTPRINT 502 FIGURE 47 SINGLE-CELL SEQUENCING SERVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 509 FIGURE 48 SINGLE-CELL SEQUENCING SERVICES MARKET: COMPANY FOOTPRINT 510 FIGURE 49 SINGLE-CELL SEQUENCING MARKET: COMPANY EVALUATION MATRIX, (STARTUPS/SMES), 2024 514 FIGURE 50 EV/EBITDA OF KEY VENDORS 518 FIGURE 51 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 518 FIGURE 52 SINGLE-CELL SEQUENCING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 519 FIGURE 53 BD: COMPANY SNAPSHOT (2024) 525 FIGURE 54 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024) 532 FIGURE 55 DANAHER CORPORATION: COMPANY SNAPSHOT (2024) 537 FIGURE 56 10X GENOMICS: COMPANY SNAPSHOT (2024) 542 FIGURE 57 ILLUMINA, INC.: COMPANY SNAPSHOT (2024) 549 FIGURE 58 MERCK KGAA: COMPANY SNAPSHOT (2024) 555 FIGURE 59 QIAGEN N.V.: COMPANY SNAPSHOT (2024) 559 FIGURE 60 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024) 562 FIGURE 61 TECAN TRADING AG: COMPANY SNAPSHOT (2024) 566 FIGURE 62 CYTEK BIOSCIENCES: COMPANY SNAPSHOT (2024) 569 FIGURE 63 TAKARA BIO INC.: COMPANY SNAPSHOT (2024) 573 FIGURE 66 AZENTA US INC.: COMPANY SNAPSHOT (2024) 583 FIGURE 67 IQVIA INC.: COMPANY SNAPSHOT (2024) 589

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們